(R)-(1,3-dimethylazetidin-3-yl)-(5-pyrrolidin-1-yl-3-pyridinyl)-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]methanol
C25H30F3N3O — CID 157026130
Data last refreshed: (MolForge compound catalog, from PubChem)
About (R)-(1,3-dimethylazetidin-3-yl)-(5-pyrrolidin-1-yl-3-pyridinyl)-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]methanol
(R)-(1,3-dimethylazetidin-3-yl)-(5-pyrrolidin-1-yl-3-pyridinyl)-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]methanol (PubChem CID 157026130) has the molecular formula C25H30F3N3O and a molecular weight of 445.53 g/mol. Its IUPAC name is (R)-(1,3-dimethylazetidin-3-yl)-(5-pyrrolidin-1-yl-3-pyridinyl)-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]methanol.
Molecular Properties
| Compound Name | (R)-(1,3-dimethylazetidin-3-yl)-(5-pyrrolidin-1-yl-3-pyridinyl)-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]methanol |
|---|---|
| PubChem CID | 157026130 |
| Molecular Formula | C25H30F3N3O |
| Molecular Weight | 445.53 g/mol |
| Exact Mass | 445.23 |
| IUPAC Name | (R)-(1,3-dimethylazetidin-3-yl)-(5-pyrrolidin-1-yl-3-pyridinyl)-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]methanol |
| SMILES | CN1CC(C)([C@](O)(c2ccc(C3(C(F)(F)F)CC3)cc2)c2cncc(N3CCCC3)c2)C1 |
| InChI | InChI=1S/C25H30F3N3O/c1-22(16-30(2)17-22)24(32,20-13-21(15-29-14-20)31-11-3-4-12-31)19-7-5-18(6-8-19)23(9-10-23)25(26,27)28/h5-8,13-15,32H,3-4,9-12,16-17H2,1-2H3/t24-/m0/s1 |
| InChIKey | MSJOFVYJQWFCDL-DEOSSOPVSA-N |
| XLogP | 4.46 |
| TPSA | 39.60 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.53 |
| LogP ≤ 5 | 4.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157026130 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.